8-KMaterial AgreementsExhibits & Filings

CVS HEALTH Corp 8-K Report, Material Agreement (Nov 7, 2007)

Filed November 7, 2007For Securities:CVS

Summary

CVS Health Corporation (CVS) filed an 8-K on November 7, 2007, detailing a significant financial transaction. The company entered into a new accelerated share repurchase (ASR) agreement with an affiliate of Lehman Brothers, Inc., for approximately $2.3 billion. This transaction is part of a previously announced $5.0 billion share repurchase program, with $2.5 billion already utilized in a prior ASR transaction settled in October 2007. The new ASR aims to reduce outstanding shares and return capital to shareholders, with the final number of repurchased shares contingent on the average stock price over a defined future period.

Key Highlights

  • 1CVS Caremark Corporation entered into a new accelerated share repurchase (ASR) transaction for approximately $2.3 billion on November 6, 2007.
  • 2This ASR is a component of the previously authorized $5.0 billion share repurchase program.
  • 3An affiliate of Lehman Brothers, Inc. is the counterparty for this ASR transaction.
  • 4A prior ASR transaction of $2.5 billion with Lehman Brothers was finalized on October 5, 2007.
  • 5The total number of shares repurchased in this new ASR will be determined by the average stock price over a specified period of approximately one to four months after an initial period.
  • 6The filing indicates the company is actively managing its capital structure and returning value to shareholders through share buybacks.

Frequently Asked Questions

The primary purpose of this Form 8-K is to report the entry into a material definitive agreement regarding a new accelerated share repurchase (ASR) transaction valued at approximately $2.3 billion.

This $2.3 billion ASR is part of CVS Health's previously announced $5.0 billion share repurchase program. It follows a previous ASR of $2.5 billion that was settled in October 2007.

The counterparty for this accelerated share repurchase transaction is an affiliate of Lehman Brothers, Inc.

The final number of shares will be determined by the average price of CVS Health's common stock over a period of approximately one to four months following an initial valuation period after the transaction's execution. This means the effective purchase price per share will fluctuate.